Turk J Hematol. 2023; 40(4): 284-285 | DOI: 10.4274/tjh.galenos.2023.2023.0263

Effect and Safety of Orelabrutinib and Lenalidomide Plus R-mini CDOP in Relapsed/Refractory Aggressive B-cell Non-Hodgkin Lymphoma

Ying Shang¹, Hongyu Zhao², Daqi Li^2
1Shandong First Medical University & Shandong Academy of Medical Sciences, Shandong, China
²Central Hospital Affiliated to Shandong First Medical University, Shandong, China

Keywords: Relapsed/refractory aggressive B-cell lymphoma, Orelabrutinib, Lenalidomide, R-mini CDOP

---

Relaps/Refrakter Agresif B-hücre Non-Hodgkin Lenfomada Orelabrutinib ve Lenalidomidle Birlikte R-Mini CDOP Kullanımının Etki ve Güvenilirliği

Ying Shang¹, Hongyu Zhao², Daqi Li^2
1Shandong First Medical University & Shandong Academy of Medical Sciences, Shandong, China
²Central Hospital Affiliated to Shandong First Medical University, Shandong, China

Anahtar Kelimeler: Relpas/refrakter agresif B-hücre lenfoma, Orelabrutinib, Lenalidomid, R-mini CDOP

---

CITE